- Home
- KALU vs RXRX Comparison
KALU vs RXRX Comparison
Compare KALU & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KALU | RXRX |
|---|---|---|
| Founded | 1946 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KALU | RXRX |
|---|---|---|
| Price | $175.91 | $3.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $147.33 | $7.50 |
| AVG Volume (30 Days) | 245.5K | ★ 9.7M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | ★ 135.89 | 14.79 |
| EPS | ★ 3.71 | N/A |
| Revenue | ★ $1,585,900,000.00 | $74,681,000.00 |
| Revenue This Year | $13.37 | $12.11 |
| Revenue Next Year | $2.62 | $82.52 |
| P/E Ratio | $47.49 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $61.84 | $2.80 |
| 52 Week High | $181.47 | $7.18 |
Technical Indicators
Market Signals| Indicator | KALU | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 78.98 | 52.33 |
| Support Level | $74.15 | $2.89 |
| Resistance Level | N/A | $3.99 |
| Average True Range (ATR) | 7.28 | 0.17 |
| MACD | 3.56 | 0.02 |
| Stochastic Oscillator | 83.36 | 44.76 |
Price Performance
Historical ComparisonAbout KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.